Literature DB >> 17238258

Comparative evaluation of MMPBSA and XSCORE to compute binding free energy in XIAP-peptide complexes.

Cristian Obiol-Pardo1, Jaime Rubio-Martinez.   

Abstract

Evaluation of binding free energy in receptor-ligand complexes is one of the most important challenges in theoretical drug design. Free energy is directly correlated to the thermodynamic affinity constant, and, as a first step in druglikeness, a lead compound must have this constant in the range of micro- to nanomolar activity. Many efforts have been made to calculate it by rigorous computational approaches, such as free energy perturbation or linear response approximation. However, these methods are still computationally expensive. We focus our work on XIAP, an antiapoptotic protein whose inhibition can lead to new drugs against cancer disease. We report here a comparative evaluation of two completely different methodologies to estimate binding free energy, MMPBSA (a force field based function) and XSCORE (an empirical scoring function), in seven XIAP-peptide complexes using a representative set of structures generated by previous molecular dynamics simulations. Both methods are able to predict the experimental binding free energy with acceptable errors, but if one needs to identify slight differences upon binding, MMPBSA performs better, although XSCORE is not a bad choice taking into account the low computational cost of this method.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17238258     DOI: 10.1021/ci600412z

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  9 in total

1.  Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors.

Authors:  Bingjie Qin; Xingkai Jiang; Hong Lu; Xingtao Tian; Florent Barbault; Li Huang; Keduo Qian; Chin-Ho Chen; Rong Huang; Shibo Jiang; Kuo-Hsiung Lee; Lan Xie
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

2.  Molecular dynamics simulations and binding free energy analysis of DNA minor groove complexes of curcumin.

Authors:  Mathew Varghese Koonammackal; Unnikrishnan Viswambharan Nair Nellipparambil; Chellappanpillai Sudarsanakumar
Journal:  J Mol Model       Date:  2011-02-02       Impact factor: 1.810

3.  Virtual screening using molecular simulations.

Authors:  Tianyi Yang; Johnny C Wu; Chunli Yan; Yuanfeng Wang; Ray Luo; Michael B Gonzales; Kevin N Dalby; Pengyu Ren
Journal:  Proteins       Date:  2011-04-12

4.  Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Authors:  Xingtao Tian; Bingjie Qin; Zhiyuan Wu; Xiaofeng Wang; Hong Lu; Susan L Morris-Natschke; Chin Ho Chen; Shibo Jiang; Kuo-Hsiung Lee; Lan Xie
Journal:  J Med Chem       Date:  2010-11-04       Impact factor: 7.446

5.  Novel method for probing the specificity binding profile of ligands: applications to HIV protease.

Authors:  Woody Sherman; Bruce Tidor
Journal:  Chem Biol Drug Des       Date:  2008-03-31       Impact factor: 2.817

6.  Molecular Structure-Based Screening of the Constituents of Calotropis procera Identifies Potential Inhibitors of Diabetes Mellitus Target Alpha Glucosidase.

Authors:  Cynthia A Adinortey; Gabriel B Kwarko; Russell Koranteng; Daniel Boison; Issaka Obuaba; Michael D Wilson; Samuel K Kwofie
Journal:  Curr Issues Mol Biol       Date:  2022-02-21       Impact factor: 2.976

7.  An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine.

Authors:  Gayathri Devi Chandramoorthi; Shanmughavel Piramanayagam; Parthiban Marimuthu
Journal:  J Mol Model       Date:  2008-05-30       Impact factor: 1.810

8.  Rational design of the survivin/CDK4 complex by combining protein-protein docking and molecular dynamics simulations.

Authors:  Jana Selent; Agnieszka A Kaczor; Ramon Guixà-González; Pau Carrió; Manuel Pastor; Cristian Obiol-Pardo
Journal:  J Mol Model       Date:  2012-12-21       Impact factor: 1.810

9.  ACID: a free tool for drug repurposing using consensus inverse docking strategy.

Authors:  Fan Wang; Feng-Xu Wu; Cheng-Zhang Li; Chen-Yang Jia; Sun-Wen Su; Ge-Fei Hao; Guang-Fu Yang
Journal:  J Cheminform       Date:  2019-11-27       Impact factor: 5.514

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.